Research of the method of reconstructing the repair bionic scaffold based on tissue engineering

Author(s):  
Lin Liulan ◽  
Liu Hanqing ◽  
Hu Qingxi ◽  
Li Limin ◽  
Fang Minglun
2019 ◽  
Vol 179 ◽  
pp. 208-217 ◽  
Author(s):  
Ruixia Hou ◽  
Xingyuan Wang ◽  
Qianqian Wei ◽  
Peipei Feng ◽  
Xianbo Mou ◽  
...  

2012 ◽  
Vol 184-185 ◽  
pp. 222-226
Author(s):  
Fan Fen Peng ◽  
Shu Xian Zheng ◽  
Jia Li

The relationship between the porosity and the mechanical property was still a bottle-neck in bone tissue engineering scaffold. Porosity increasing may reduce the scaffold strength. In order to solve the contradiction, the idea of enhancing the mechanical properties by controlling the scaffold porosity was proposed in this paper. Using reverse engineering technology, 5 different porosity cranium scaffolds were first established. Their FE models were built through FE surface preprocessing and volume fitted meshing. According to results of static analysis, the displacements and stresses of the 5 porosity scaffolds were compared and discussed and it indicated that the 36% porosity bionic scaffold have good porous level and mechanical properties.


2020 ◽  
Vol 48 (3) ◽  
pp. 755-764
Author(s):  
Benjamin B. Rothrauff ◽  
Rocky S. Tuan

Bone possesses an intrinsic regenerative capacity, which can be compromised by aging, disease, trauma, and iatrogenesis (e.g. tumor resection, pharmacological). At present, autografts and allografts are the principal biological treatments available to replace large bone segments, but both entail several limitations that reduce wider use and consistent success. The use of decellularized extracellular matrices (ECM), often derived from xenogeneic sources, has been shown to favorably influence the immune response to injury and promote site-appropriate tissue regeneration. Decellularized bone ECM (dbECM), utilized in several forms — whole organ, particles, hydrogels — has shown promise in both in vitro and in vivo animal studies to promote osteogenic differentiation of stem/progenitor cells and enhance bone regeneration. However, dbECM has yet to be investigated in clinical studies, which are needed to determine the relative efficacy of this emerging biomaterial as compared with established treatments. This mini-review highlights the recent exploration of dbECM as a biomaterial for skeletal tissue engineering and considers modifications on its future use to more consistently promote bone regeneration.


2012 ◽  
Vol 2 (1_suppl) ◽  
pp. s-0032-1319873-s-0032-1319873
Author(s):  
P. Colombier ◽  
J. Clouet ◽  
E. Miot-Noirault ◽  
A. Vidal ◽  
F. Cachin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document